These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38537607)

  • 21. Assessment of Lymphovascular Invasion in Breast Cancer Using a Combined MRI Morphological Features, Radiomics, and Deep Learning Approach Based on Dynamic Contrast-Enhanced MRI.
    Yang X; Fan X; Lin S; Zhou Y; Liu H; Wang X; Zuo Z; Zeng Y
    J Magn Reson Imaging; 2024 Jun; 59(6):2238-2249. PubMed ID: 37855421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
    Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Jul; 30(7):3834-3842. PubMed ID: 32162004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of peritumoral vascular and intratumoral radiomics to predict pathologic complete responses to neoadjuvant chemotherapy in patients with triple-negative breast cancer.
    Xie T; Gong J; Zhao Q; Wu C; Wu S; Peng W; Gu Y
    BMC Med Imaging; 2024 Jun; 24(1):136. PubMed ID: 38844842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
    Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
    Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node metastasis prediction and biological pathway associations underlying DCE-MRI deep learning radiomics in invasive breast cancer.
    Liu W; Chen W; Xia J; Lu Z; Fu Y; Li Y; Tan Z
    BMC Med Imaging; 2024 Apr; 24(1):91. PubMed ID: 38627678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing Ki-67 Prediction in Breast Cancer: Integrating Intratumoral and Peritumoral Radiomics From Automated Breast Ultrasound via Machine Learning.
    Li F; Zhu TW; Lin M; Zhang XT; Zhang YL; Zhou AL; Huang DY
    Acad Radiol; 2024 Jul; 31(7):2663-2673. PubMed ID: 38182442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics Analysis Based on Automatic Image Segmentation of DCE-MRI for Predicting Triple-Negative and Nontriple-Negative Breast Cancer.
    Ma M; Gan L; Jiang Y; Qin N; Li C; Zhang Y; Wang X
    Comput Math Methods Med; 2021; 2021():2140465. PubMed ID: 34422088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Joint Prediction of Breast Cancer Histological Grade and Ki-67 Expression Level Based on DCE-MRI and DWI Radiomics.
    Fan M; Yuan W; Zhao W; Xu M; Wang S; Gao X; Li L
    IEEE J Biomed Health Inform; 2020 Jun; 24(6):1632-1642. PubMed ID: 31794406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].
    Zhang Y; Huang H; Yin L; Wang ZX; Lu SY; Wang XX; Xiang LL; Zhang Q; Zhang JL; Shan XH
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):428-437. PubMed ID: 38742356
    [No Abstract]   [Full Text] [Related]  

  • 30. Predicting disease recurrence in breast cancer patients using machine learning models with clinical and radiomic characteristics: a retrospective study.
    Azeroual S; Ben-Bouazza FE; Naqi A; Sebihi R
    J Egypt Natl Canc Inst; 2024 Jun; 36(1):20. PubMed ID: 38853190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor immune microenvironment-based clusters in predicting prognosis and guiding immunotherapy in breast cancer.
    Liu Y; He X; Yang YI
    J Biosci; 2024; 49():. PubMed ID: 38287674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomic machine learning for predicting prognostic biomarkers and molecular subtypes of breast cancer using tumor heterogeneity and angiogenesis properties on MRI.
    Lee JY; Lee KS; Seo BK; Cho KR; Woo OH; Song SE; Kim EK; Lee HY; Kim JS; Cha J
    Eur Radiol; 2022 Jan; 32(1):650-660. PubMed ID: 34226990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
    Yu Y; Fan Y; Wang X; Zhu M; Hu M; Shi C; Hu C
    Eur Radiol; 2022 Feb; 32(2):959-970. PubMed ID: 34480625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional generative adversarial network driven radiomic prediction of mutation status based on magnetic resonance imaging of breast cancer.
    Huang ZH; Chen L; Sun Y; Liu Q; Hu P
    J Transl Med; 2024 Mar; 22(1):226. PubMed ID: 38429796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study.
    Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X
    Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
    Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
    World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging Phenotypes of Breast Cancer Heterogeneity in Preoperative Breast Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) Scans Predict 10-Year Recurrence.
    Chitalia RD; Rowland J; McDonald ES; Pantalone L; Cohen EA; Gastounioti A; Feldman M; Schnall M; Conant E; Kontos D
    Clin Cancer Res; 2020 Feb; 26(4):862-869. PubMed ID: 31732521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiling regulatory T lymphocytes within the tumor microenvironment of breast cancer via radiomics.
    Jiang W; Wu R; Yang T; Yu S; Xing W
    Cancer Med; 2023 Dec; 12(24):21861-21872. PubMed ID: 38083903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AI-powered interpretable imaging phenotypes noninvasively characterize tumor microenvironment associated with diverse molecular signatures and survival in breast cancer.
    Lv T; Hong X; Liu Y; Miao K; Sun H; Li L; Deng C; Jiang C; Pan X
    Comput Methods Programs Biomed; 2024 Jan; 243():107857. PubMed ID: 37865058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.